Zhejiang Xianju Pharmaceutical Co.,Ltd. (002332.SZ)
CNY 10.64
(0.09%)
CNY 10.64
(0.09%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 598.48 Million | 609.28 Million | 676.15 Million | 789.23 Million | 519.8 Million | 193.26 Million |
| Net Income | 563.08 Million | 747.38 Million | 617.87 Million | 528.99 Million | 442.47 Million | 345.37 Million |
| Depreciation & Amortization | 220.08 Million | 193 Million | 189.51 Million | 177.1 Million | 135.12 Million | 126.43 Million |
| Deferred income taxes | 6.75 Million | 42.68 Thousand | 1.54 Million | 3.71 Million | -4.61 Million | -825.99 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -239.84 Million | -232.17 Million | -117.02 Million | -4.04 Million | -185.16 Million | -368.66 Million |
| Other non-cash items | 728.41 Million | -98.92 Million | -14.22 Million | 87.17 Million | 127.36 Million | 90.12 Million |
| Investing Cash Flow | -199.63 Million | 358.06 Million | -222.94 Million | -574.59 Million | -211.36 Million | 72.7 Million |
| Investments in PPE | -234.63 Million | -282.54 Million | -266.84 Million | -118.17 Million | -262.34 Million | -169.25 Million |
| Acquisitions | 51.33 Million | 69.87 Million | 37.74 Million | 1.4 Million | 16.04 Million | - |
| Investment purchases | -16.33 Million | -24.44 Million | -20.79 Million | -350 Thousand | -11.86 Million | -33.06 Million |
| Sales/Maturities of investments | 3 Million | 21.5 Million | 17.68 Million | 20.54 Million | 15.25 Million | 37.18 Million |
| Other Investing Activities | 1.8 Million | 573.68 Million | 9.27 Million | -478.02 Million | 31.54 Million | 237.84 Million |
| Financing Cash Flow | -463.84 Million | -422.43 Million | -484.13 Million | 309.92 Million | -166.64 Million | -293.3 Million |
| Debt repayment | -147.1 Million | -578.64 Million | -803.4 Million | -611.73 Million | -1.1 Billion | -1.09 Billion |
| Dividends payments | -296.76 Million | -148.38 Million | -148.38 Million | -91.65 Million | -59.55 Million | -125.28 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | -2.64 Million | - | - |
| Other Financing Activities | -9.58 Million | 310.43 Million | 491.39 Million | 1.06 Billion | 1.05 Billion | 923.47 Million |
| Accounts receivables | -203.22 Million | -129.77 Million | 69.03 Million | 3.3 Million | -168.91 Million | -274.5 Million |
| Accounts payables | 69.35 Million | -9.79 Million | 24.19 Million | 94.98 Million | 52.25 Million | 94.11 Million |
| Inventory | -105.97 Million | -92.64 Million | -211.2 Million | -106.04 Million | -63.88 Million | -201.65 Million |
| Other working capital | 76.11 Million | 42.68 Thousand | 951.45 Thousand | 3.71 Million | -4.61 Million | -167 Million |
| Cash at beginning of period | 1.72 Billion | 1.13 Billion | 1.19 Billion | 702.58 Million | 559.48 Million | 583.72 Million |
| Cash at end of period | 1.66 Billion | 1.7 Billion | 1.13 Billion | 1.19 Billion | 702.58 Million | 559.48 Million |
| Capital Expenditure | -234.63 Million | -282.54 Million | -266.84 Million | -118.17 Million | -262.34 Million | -169.25 Million |
| Effect of forex changes on cash | -13.43 Million | 28.17 Million | -32.71 Million | -28.31 Million | 1.3 Million | 3.08 Million |
| Net cash flow / Change in cash | -60.42 Million | 573.08 Million | -63.63 Million | 496.25 Million | 143.09 Million | -24.24 Million |
| Free Cash Flow | 363.85 Million | 326.74 Million | 409.31 Million | 671.06 Million | 257.46 Million | 24.01 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 190.45 Million | 188.6 Million | 151.12 Million | 563.08 Million | 91.48 Million | 169.79 Million |
| Depreciation & Amortization | - | 53.04 Million | 53.04 Million | 220.08 Million | 58.1 Million | 58.1 Million |
| Deferred income taxes | - | - | - | 6.75 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -239.84 Million | -309.2 Million | - |
| Other non-cash items | -66.13 Million | -149.27 Million | -42.09 Million | 728.41 Million | 72.97 Million | 76.5 Million |
| Investing Cash Flow | -66.96 Million | -11.24 Million | -63.75 Million | -199.63 Million | -85.88 Million | -42.3 Million |
| Investments in PPE | -69.04 Million | -60.53 Million | -39.87 Million | -234.63 Million | -82.24 Million | -38.67 Million |
| Acquisitions | 176.97 Thousand | 49.28 Million | 111.72 Thousand | 51.33 Million | -1.5 Million | 72.93 Thousand |
| Investment purchases | -300 Thousand | - | -40 Million | -16.33 Million | -328.52 Thousand | -5.9 Million |
| Sales/Maturities of investments | 2.2 Million | - | 16 Million | 3 Million | - | 2.2 Million |
| Other Investing Activities | 176.97 Thousand | 49.28 Million | -23.88 Million | 1.8 Million | -1.8 Million | 0.80 |
| Financing Cash Flow | -73.81 Million | -325.99 Million | -15.19 Million | -463.84 Million | -67.08 Million | -51.08 Million |
| Debt repayment | -69.5 Million | -26.66 Million | -12.18 Million | -147.1 Million | -60.23 Million | -42.78 Million |
| Dividends payments | -527.2 Thousand | -296.39 Million | -508.73 Thousand | -296.76 Million | -296.76 Million | -1.45 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.77 Million | 1.17 Million | -3.01 Million | -9.58 Million | 300.3 Million | -6.84 Million |
| Accounts receivables | - | - | - | -203.22 Million | -203.22 Million | - |
| Accounts payables | - | - | - | 69.35 Million | - | - |
| Inventory | - | - | - | -105.97 Million | -105.97 Million | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.29 Billion | 1.66 Billion | 1.66 Billion | 1.72 Billion | 1.73 Billion | 1.58 Billion |
| Cash at end of period | 1.28 Billion | 1.31 Billion | 1.66 Billion | 1.66 Billion | 1.66 Billion | 1.7 Billion |
| Capital Expenditure | -69.04 Million | -60.53 Million | -39.87 Million | -234.63 Million | -82.24 Million | -38.67 Million |
| Effect of forex changes on cash | 10.54 Million | 4.26 Million | -15.77 Million | -13.43 Million | -33.32 Million | -25.72 Million |
| Net cash flow / Change in cash | -8.12 Million | -355.11 Million | 7.31 Million | -60.42 Million | -74.85 Million | 127.2 Million |
| Free Cash Flow | 55.27 Million | -74.24 Million | 69.15 Million | 363.85 Million | 24.1 Million | 207.62 Million |
3122
450080
0547
6986
NTST
6224